Teleflex 13G Filing Shows Janus Henderson Group Plc Reported A 10.3% Stake In The Company As Of November 30, 2023
Teleflex 13G Filing Shows Janus Henderson Group Plc Reported A 10.3% Stake In The Company As Of November 30, 2023
Madrigal Pharmaceutical 13G Filing Shows Janus Henderson Group PLC Holds 15.4% Stake In Company As Of September 29, 2023
Madrigal Pharmaceutical 13G Filing Shows Janus Henderson Group PLC Holds 15.4% Stake In Company As Of September 29, 2023
Soleno Therapeutics 13G Filing Shows Janus Henderson Group Plc Holds 10.1% Stake In Co
Soleno Therapeutics 13G Filing Shows Janus Henderson Group Plc Holds 10.1% Stake In Co
Janus Henderson Group Plc Reported 10.5% Passive Stake In Ardelyx in 13G Filing As Of Dec 30, 2022
Janus Henderson Group Plc Reported 10.5% Passive Stake In Ardelyx in 13G Filing As Of Dec 30, 2022
RBC Cuts Price Target on Brookfield Asset Management to $61 From $66, Maintains Outperform Rating
06:44 AM EDT, 10/24/2022 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may co
Asset Management One Co. Ltd. Trims Stock Holdings in Organon & Co. (NYSE:OGN)
Asset Management One Co. Ltd. lowered its holdings in Organon & Co. (NYSE:OGN – Get Rating) by 32.8% in the second quarter, according to its most recent Form 13F filing with the SEC. The fund ow